Positive Study ResultsConsistent success in studies, including a >500 patient study, suggests that Petros' technology works as intended, effectively selecting against concomitant nitrate use.
Regulatory ClarityThe finalized ACNU pathway should further de-risk development and provide greater clarity in terms of regulatory standards, study designs, and development costs.
Technology EffectivenessPetros' Web App Technology has shown statistically significantly higher rates of correct self-selection for erectile dysfunction compared to the traditional Drug Facts Label.